In mouse models of breast cancer, SAB has been shown to reduce oxidative stress, induce apoptosis, inhibit inflammation and angiogenesis, and thereby hinder tumor growth (Katary et al., 2019). Here, SH3BP5 is linked to breast carcinoma.